Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FBCG
2051
Fidelity Blue Chip Growth ETF
FBCG
$7.32B
| $2.01M | ﹤0.01% |
+43,500
| New | +$1.97M |
|
2052
Sonida Senior Living
SNDA
$1.88B
| $2.01M | ﹤0.01% |
86,991
-12,277
| -12% | -$301K |
|
2053
Immunovant
IMVT
$8.64B
| $2M | ﹤0.01% |
80,900
-108,100
| -57% | -$3.07M |
|
|
BHR
2054
Braemar Hotels & Resorts
BHR
$139M
| $2M | ﹤0.01% |
667,100
+15,100
| +2% | +$48.9K |
|
2055
AC Immune
ACIU
$253M
| $2M | ﹤0.01% |
740,198
+94,191
| +15% | +$294K |
|
2056
Larimar Therapeutics
LRMR
$453M
| $1.99M | ﹤0.01% |
513,542
+159,700
| +45% | +$1.05M |
|
|
AFCG
2057
AFC Gamma
AFCG
$72.1M
| $1.98M | ﹤0.01% |
237,900
+75,900
| +47% | +$729K |
|
2058
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
| $1.98M | ﹤0.01% |
9,300
+700
| +8% | +$149K |
|
2059
Barnes & Noble Education
BNED
$421M
| $1.98M | ﹤0.01% |
+196,764
| New | +$2.02M |
|
2060
Scholar Rock
SRRK
$6.4B
| $1.98M | ﹤0.01% |
45,700
-187,600
| -80% | -$6.11M |
|
|
TIXT
2061
DELISTED
TELUS International
TIXT
| $1.97M | ﹤0.01% |
502,800
+210,400
| +72% | +$797K |
|
2062
Oil States International
OIS
$539M
| $1.97M | ﹤0.01% |
388,386
+61,087
| +19% | +$304K |
|
2063
Vanguard Morningstar Value ETF
VTV
$194B
| $1.96M | ﹤0.01% |
11,600
-4,700
| -29% | -$825K |
|
2064
B&G Foods
BGS
$294M
| $1.96M | ﹤0.01% |
284,300
-138,000
| -33% | -$1.04M |
|
2065
Talos Energy
TALO
$2.63B
| $1.96M | ﹤0.01% |
201,500
+44,315
| +28% | +$466K |
|
2066
Compugen
CGEN
$228M
| $1.95M | ﹤0.01% |
1,277,200
-9,900
| -0.8% | -$16.1K |
|
2067
Seer Inc
SEER
$115M
| $1.95M | ﹤0.01% |
843,700
+179,568
| +27% | +$394K |
|
|
SEZL
2068
Sezzle
SEZL
$4.34B
| $1.94M | ﹤0.01% |
45,600
+6,000
| +15% | +$283K |
|
2069
Skillsoft
SKIL
$74.2M
| $1.94M | ﹤0.01% |
81,080
+6,000
| +8% | +$98K |
|
2070
SR Bancorp
SRBK
$146M
| $1.94M | ﹤0.01% |
163,000
-7,700
| -5% | -$87.4K |
|
2071
Invesco S&P MidCap Quality ETF
XMHQ
$5.68B
| $1.94M | ﹤0.01% |
+19,700
| New | +$2.04M |
|
|
SII
2072
Sprott
SII
$3B
| $1.94M | ﹤0.01% |
46,000
+6,300
| +16% | +$277K |
|
|
CTV
2073
DELISTED
Innovid Corp.
CTV
| $1.93M | ﹤0.01% |
626,157
+249,100
| +66% | +$588K |
|
2074
Black Diamond Therapeutics
BDTX
$116M
| $1.93M | ﹤0.01% |
904,000
+650,200
| +256% | +$1.86M |
|
|
GRSD
2075
Grandstand Limited Ordinary Shares
GRSD
$80.4M
| $1.93M | ﹤0.01% |
137,084
-93,444
| -41% | -$1.1M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.